Adjuvance Technologies Announces Issuance of U.S. Patent Covering Semi-Synthetic Saponin Adjuvants
Adjuvance Technologies, a Bio Nebraska member, announced today it received a patent (U.S. Patent No. 10,906,926) for its TQL-1055 adjuvant, which is currently used in available shingles vaccines. Read more